Alset Inc. (AEI)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	46	9	10	17	36	51
Market Cap Growth	65.32%	-0.97%	-44.30%	-52.65%	-29.61%	-
Enterprise Value	5	-22	-59	-76	-72	28
Last Close Price	1.17	1.02	1.03	2.30	11.16	119.60
PS Ratio	0.70	0.45	0.43	3.81	1.82	3.16
PB Ratio	0.16	0.10	0.10	0.12	0.21	0.52
P/TBV Ratio	0.60	0.12	0.11	0.12	0.24	0.86
P/FCF Ratio	16.74	1.86	1.28	-	-	173.17
P/OCF Ratio	15.80	1.83	1.27	-	-	161.36
EV/Sales Ratio	0.32	-	-	-	-	1.71
EV/FCF Ratio	1.89	-	-	-	-	93.73
Debt / Equity Ratio	0.03	0.03	0.02	0.01	0.01	0.04
Debt / EBITDA Ratio	-	-	5.81	-	-	-
Debt / FCF Ratio	0.98	0.59	0.23	-	-	13.24
Asset Turnover	0.17	0.19	0.16	0.03	0.14	0.23
Inventory Turnover	1574.98	2440.83	718.39	90.68	164.56	116.90
Quick Ratio	10.27	10.07	6.33	28.01	9.16	8.60
Current Ratio	11.22	10.91	6.84	29.41	10.54	9.61
Return on Equity (ROE)	-7.27%	-4.46%	-49.93%	-28.98%	-88.72%	-7.79%
Return on Assets (ROA)	-2.66%	-1.40%	-0.90%	-2.62%	-6.42%	-1.90%
Return on Capital (ROIC)	-2.76%	-1.63%	-1.01%	-2.75%	-6.84%	-2.10%
Earnings Yield	-12.03%	-42.10%	-619.69%	-237.09%	-286.44%	-6.15%
FCF Yield	5.98%	53.64%	78.32%	-190.04%	-46.88%	0.58%
Buyback Yield / Dilution	-3.94%	-2.14%	-38.82%	-365.53%	-235.03%	16.48%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q